{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:59:11Z","timestamp":1785416351397,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-024-03766-5","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T14:25:13Z","timestamp":1732199113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Longitudinal decline in DAT binding in Parkinson\u2019s disease: connections with sleep disturbances"],"prefix":"10.1186","volume":"22","author":[{"given":"Junli","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haobo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoying","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruotong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"issue":"6","key":"3766_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s10072-019-03785-8","volume":"40","author":"SW Yoo","year":"2019","unstructured":"Yoo SW, Kim JS, Oh YS, Ryu DW, Lee KS. Excessive daytime sleepiness and its impact on quality of life in de novo Parkinson\u2019s disease. Neurol Sci. 2019;40(6):1151\u20136.","journal-title":"Neurol Sci"},{"key":"3766_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jocn.2017.09.019","volume":"47","author":"Y Kim","year":"2018","unstructured":"Kim Y, Kim YE, Park EO, Shin CW, Kim HJ, Jeon B. REM sleep behavior disorder portends poor prognosis in Parkinson\u2019s disease: a systematic review. J Clin Neurosci. 2018;47:6\u201313.","journal-title":"J Clin Neurosci"},{"issue":"3","key":"3766_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jsmc.2022.06.012","volume":"17","author":"T Ono","year":"2022","unstructured":"Ono T, Takenoshita S, Nishino S. Pharmacologic management of excessive daytime sleepiness. Sleep Med Clin. 2022;17(3):485\u2013503.","journal-title":"Sleep Med Clin"},{"key":"3766_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jns.2017.08.3247","volume":"382","author":"T Nomura","year":"2017","unstructured":"Nomura T, Kishi M, Nakashima K. Differences in clinical characteristics when REM sleep behavior disorder precedes or comes after the onset of Parkinson\u2019s disease. J Neurol Sci. 2017;382:58\u201360.","journal-title":"J Neurol Sci"},{"issue":"11","key":"3766_CR5","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.mayocp.2017.09.007","volume":"92","author":"EK St Louis","year":"2017","unstructured":"St Louis EK, Boeve BF. REM sleep behavior disorder: diagnosis, clinical implications, and future directions. Mayo Clin Proc. 2017;92(11):1723\u201336.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"3766_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccm.2010.02.004","volume":"31","author":"BS Lu","year":"2010","unstructured":"Lu BS, Zee PC. Neurobiology of sleep. Clin Chest Med. 2010;31(2):309\u201318.","journal-title":"Clin Chest Med"},{"issue":"9","key":"3766_CR7","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, et al. Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord. 2017;32(9):1264\u2013310.","journal-title":"Mov Disord"},{"key":"3766_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40035-017-0076-6","volume":"6","author":"U Saeed","year":"2017","unstructured":"Saeed U, Compagnone J, Aviv RI, Strafella AP, Black SE, Lang AE, Masellis M. Imaging biomarkers in Parkinson\u2019s disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener. 2017;6:8.","journal-title":"Transl Neurodegener"},{"key":"3766_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2020.02.001","volume":"72","author":"R Liu","year":"2020","unstructured":"Liu R, Umbach DM, Tr\u00f6ster AI, Huang X, Chen H. Non-motor symptoms and striatal dopamine transporter binding in early Parkinson\u2019s disease. Parkinsonism Relat Disord. 2020;72:23\u201330.","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"3766_CR10","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/ene.13388","volume":"24","author":"SJ Chung","year":"2017","unstructured":"Chung SJ, Lee Y, Lee JJ, Lee PH, Sohn YH. Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson\u2019s disease. Eur J Neurol. 2017;24(10):1314\u20139.","journal-title":"Eur J Neurol"},{"issue":"Pt 6","key":"3766_CR11","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/brain\/123.6.1155","volume":"123","author":"I Eisensehr","year":"2000","unstructured":"Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder: comparison with Parkinson\u2019s disease and controls. Brain. 2000;123(Pt 6):1155\u201360.","journal-title":"Brain"},{"issue":"3","key":"3766_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/mds.27282","volume":"33","author":"AJ Noyce","year":"2018","unstructured":"Noyce AJ, Dickson J, Rees RN, Bestwick JP, Isaias IU, Politis M, Giovannoni G, Warner TT, Lees AJ, Schrag A. Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson\u2019s disease. Mov Disord. 2018;33(3):478\u201382.","journal-title":"Mov Disord"},{"issue":"5","key":"3766_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/sleep\/26.5.507","volume":"26","author":"I Eisensehr","year":"2003","unstructured":"Eisensehr I, Linke R, Tatsch K, Kharraz B, Gildehaus JF, Wetter CT, Trenkwalder C, Schwarz J, Noachtar S. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson\u2019s disease, and controls. Sleep. 2003;26(5):507\u201312.","journal-title":"Sleep"},{"key":"3766_CR14","doi-asserted-by":"publisher","unstructured":"The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol. 2011;95(4):629\u201335. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.09.005.","DOI":"10.1016\/j.pneurobio.2011.09.005"},{"issue":"7","key":"3766_CR15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1212\/WNL.58.7.1019","volume":"58","author":"I Arnulf","year":"2002","unstructured":"Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblez L, Golmard JL, Derenne JP, Agid Y. Parkinson\u2019s disease and sleepiness: an integral part of PD. Neurology. 2002;58(7):1019\u201324.","journal-title":"Neurology"},{"issue":"16","key":"3766_CR16","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.21740","volume":"22","author":"K Stiasny-Kolster","year":"2007","unstructured":"Stiasny-Kolster K, Mayer G, Sch\u00e4fer S, M\u00f6ller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire\u2013a new diagnostic instrument. Mov Disord. 2007;22(16):2386\u201393.","journal-title":"Mov Disord"},{"issue":"7","key":"3766_CR17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.sleep.2011.01.015","volume":"12","author":"T Nomura","year":"2011","unstructured":"Nomura T, Inoue Y, Kagimura T, Uemura Y, Nakashima K. Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson\u2019s disease patients. Sleep Med. 2011;12(7):711\u20133.","journal-title":"Sleep Med"},{"issue":"12","key":"3766_CR18","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u2013601.","journal-title":"Mov Disord"},{"issue":"14","key":"3766_CR19","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJM198804073181402","volume":"318","author":"SJ Kish","year":"1988","unstructured":"Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson\u2019s disease. Pathophysiologic and clinical implications. N Engl J Med. 1988;318(14):876\u201380.","journal-title":"N Engl J Med"},{"issue":"2 Suppl 2","key":"3766_CR20","first-page":"S2","volume":"51","author":"O Hornykiewicz","year":"1998","unstructured":"Hornykiewicz O. Biochemical aspects of Parkinson\u2019s disease. Neurology. 1998;51(2 Suppl 2):S2-9.","journal-title":"Neurology"},{"issue":"2\u20133","key":"3766_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","volume":"5","author":"SL Alberico","year":"2015","unstructured":"Alberico SL, Cassell MD, Narayanan NS. The vulnerable ventral tegmental area in Parkinson\u2019s disease. Basal Ganglia. 2015;5(2\u20133):51\u20135.","journal-title":"Basal Ganglia"},{"issue":"1","key":"3766_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.31083\/j.jin2201018","volume":"22","author":"IH Kwak","year":"2023","unstructured":"Kwak IH, Lee YK, Ma HI, Lee S, Yun M, Kim YJ, Hwang HS, Kim YE. Striatal subregion analysis associated with REM sleep behavior disorder in Parkinson\u2019s disease. J Integr Neurosci. 2023;22(1):18.","journal-title":"J Integr Neurosci"},{"issue":"1","key":"3766_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40035-022-00294-1","volume":"11","author":"J Huang","year":"2022","unstructured":"Huang J, Cheng Y, Li C, Shang H. Genetic heterogeneity on sleep disorders in Parkinson\u2019s disease: a systematic review and meta-analysis. Transl Neurodegener. 2022;11(1):21.","journal-title":"Transl Neurodegener"},{"issue":"10","key":"3766_CR24","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1093\/hmg\/ddaa085","volume":"29","author":"ME Gegg","year":"2020","unstructured":"Gegg ME, Verona G, Schapira AHV. Glucocerebrosidase deficiency promotes release of \u03b1-synuclein fibrils from cultured neurons. Hum Mol Genet. 2020;29(10):1716\u201328.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"3766_CR25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/mds.27884","volume":"35","author":"S Lerche","year":"2020","unstructured":"Lerche S, Wurster I, Roeben B, Zimmermann M, Riebenbauer B, Deuschle C, Hauser AK, Schulte C, Berg D, Maetzler W, et al. Parkinson\u2019s disease: glucocerebrosidase 1 mutation severity is associated with CSF alpha-synuclein profiles. Mov Disord. 2020;35(3):495\u20139.","journal-title":"Mov Disord"},{"issue":"7","key":"3766_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol. 2008;7(7):583\u201390.","journal-title":"Lancet Neurol"},{"issue":"5","key":"3766_CR27","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ana.20456","volume":"57","author":"JO Aasly","year":"2005","unstructured":"Aasly JO, Toft M, Fernandez-Mata I, Kachergus J, Hulihan M, White LR, Farrer M. Clinical features of LRRK2-associated Parkinson\u2019s disease in central Norway. Ann Neurol. 2005;57(5):762\u20135.","journal-title":"Ann Neurol"},{"issue":"1","key":"3766_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","volume":"72","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 2015;72(1):100\u20135.","journal-title":"JAMA Neurol"},{"issue":"4","key":"3766_CR29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.22691","volume":"71","author":"V Kotagal","year":"2012","unstructured":"Kotagal V, Albin RL, M\u00fcller ML, Koeppe RA, Chervin RD, Frey KA, Bohnen NI. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol. 2012;71(4):560\u20138.","journal-title":"Ann Neurol"},{"issue":"13","key":"3766_CR30","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/mds.26412","volume":"30","author":"M Ehrminger","year":"2015","unstructured":"Ehrminger M, Leu-Semenescu S, Cormier F, Corvol JC, Vidailhet M, Debellemaniere E, Brice A, Arnulf I. Sleep aspects on video-polysomnography in LRRK2 mutation carriers. Mov Disord. 2015;30(13):1839\u201343.","journal-title":"Mov Disord"},{"issue":"3","key":"3766_CR31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/acn3.51301","volume":"8","author":"J Yang","year":"2021","unstructured":"Yang J, Wang H, Yuan Y, Fan S, Li L, Jiang C, Mao C, Shi C, Xu Y. Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants. Ann Clin Transl Neurol. 2021;8(3):592\u2013602.","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"3766_CR32","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/mds.28667","volume":"36","author":"R Isonaka","year":"2021","unstructured":"Isonaka R, Goldstein DS, Zhu W, Yoon E, Ehrlich D, Schindler AB, Kokkinis AD, Sabir MS, Scholz SW, Bandres-Ciga S, et al. \u03b1-Synuclein deposition in sympathetic nerve fibers in genetic forms of Parkinson\u2019s disease. Mov Disord. 2021;36(10):2346\u201357.","journal-title":"Mov Disord"},{"issue":"4","key":"3766_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ana.25687","volume":"87","author":"L Krohn","year":"2020","unstructured":"Krohn L, Wu RYJ, Heilbron K, Ruskey JA, Laurent SB, Blauwendraat C, Alam A, Arnulf I, Hu MTM, Dauvilliers Y, et al. Fine-mapping of SNCA in rapid eye movement sleep behavior disorder and overt synucleinopathies. Ann Neurol. 2020;87(4):584\u201398.","journal-title":"Ann Neurol"},{"issue":"1","key":"3766_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3988\/jcn.2019.15.1.102","volume":"15","author":"S Shin","year":"2019","unstructured":"Shin S, Kim K, Lee JM, Kim EJ, Kim SJ, Kim IJ, Pak K, Lee MJ. Effect of single-nucleotide polymorphisms on decline of dopamine transporter availability in Parkinson\u2019s disease. J Clin Neurol. 2019;15(1):102\u20137.","journal-title":"J Clin Neurol"},{"issue":"10","key":"3766_CR35","doi-asserted-by":"publisher","first-page":"e864","DOI":"10.1212\/WNL.0000000000005063","volume":"90","author":"C Koros","year":"2018","unstructured":"Koros C, Stamelou M, Simitsi A, Beratis I, Papadimitriou D, Papagiannakis N, Fragkiadaki S, Kontaxopoulou D, Papageorgiou SG, Stefanis L. Selective cognitive impairment and hyposmia in p.A53T SNCA PD vs typical PD. Neurology. 2018;90(10):e864\u20139.","journal-title":"Neurology"},{"issue":"3","key":"3766_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00401-010-0723-9","volume":"120","author":"WT Hu","year":"2010","unstructured":"Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Karlawish J, Hurtig HI, et al. Biomarker discovery for Alzheimer\u2019s disease, frontotemporal lobar degeneration, and Parkinson\u2019s disease. Acta Neuropathol. 2010;120(3):385\u201399.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3766_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40478-018-0560-y","volume":"6","author":"LC Beauchamp","year":"2018","unstructured":"Beauchamp LC, Chan J, Hung LW, Padman BS, Vella LJ, Liu XM, Coleman B, Bush AI, Lazarou M, Hill AF, et al. Ablation of tau causes an olfactory deficit in a murine model of Parkinson\u2019s disease. Acta Neuropathol Commun. 2018;6(1):57.","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"3766_CR38","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jalz.2016.04.003","volume":"12","author":"M Shi","year":"2016","unstructured":"Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, et al. CNS tau efflux via exosomes is likely increased in Parkinson\u2019s disease but not in Alzheimer\u2019s disease. Alzheimers Dement. 2016;12(11):1125\u201331.","journal-title":"Alzheimers Dement"},{"issue":"5866","key":"3766_CR39","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1126\/science.1152993","volume":"319","author":"R Dixit","year":"2008","unstructured":"Dixit R, Ross JL, Goldman YE, Holzbaur EL. Differential regulation of dynein and kinesin motor proteins by tau. Science. 2008;319(5866):1086\u20139.","journal-title":"Science"},{"issue":"1","key":"3766_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17(1):5\u201321.","journal-title":"Nat Rev Neurosci"},{"issue":"17","key":"3766_CR41","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1523\/JNEUROSCI.4261-13.2014","volume":"34","author":"ML Frandemiche","year":"2014","unstructured":"Frandemiche ML, De Seranno S, Rush T, Borel E, Elie A, Arnal I, Lant\u00e9 F, Buisson A. Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers. J Neurosci. 2014;34(17):6084\u201397.","journal-title":"J Neurosci"},{"issue":"11","key":"3766_CR42","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S1474-4422(10)70216-7","volume":"9","author":"A Iranzo","year":"2010","unstructured":"Iranzo A, Lome\u00f1a F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, Molinuevo JL, Serradell M, Duch J, Pav\u00eda J, et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. Lancet Neurol. 2010;9(11):1070\u20137.","journal-title":"Lancet Neurol"},{"issue":"9","key":"3766_CR43","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S1474-4422(11)70152-1","volume":"10","author":"A Iranzo","year":"2011","unstructured":"Iranzo A, Valldeoriola F, Lome\u00f1a F, Molinuevo JL, Serradell M, Salamero M, Cot A, Ros D, Pav\u00eda J, Santamaria J, et al. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol. 2011;10(9):797\u2013805.","journal-title":"Lancet Neurol"},{"issue":"Pt 5","key":"3766_CR44","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ. Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain. 1991;114(Pt 5):2283\u2013301.","journal-title":"Brain"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-024-03766-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T16:02:48Z","timestamp":1732204968000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-024-03766-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3766"],"URL":"https:\/\/doi.org\/10.1186\/s12916-024-03766-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data used in the preparation of this article were obtained on [2023-08-19] from the PPMI database (), RRID: SCR_006431. For up-to-date information on the study, visit . All participating institutions\u2019 regional ethical committees approved the PPMI, and written informed consent were obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"550"}}